CRO

India primed for biostatic outsourcing boom; CMO Aenove sold for $782M;

> India's market for the outsourcing of biostatic research is set to boom thanks to competitive pricing and burgeoning infrastructure, according to Beroe. News

> Bridgeport sold Munich-based CMO Aenove Group to BC Partners for a reported $782 million. The company operates in 5 countries across Europe and North America and has about 1,600 employees. Article

> The EMA is seeking CRO and sponsor input on a proposal to publicize more raw clinical trial data. The agency is looking to support independent research and public health without breaching patient confidentiality. Item

> India's custom research and manufacturing industry is also predicted to explode, with analysts forecasting 41.4% growth--more than three times the rate in the rest of the world. More

> German CRO Verum.de is targeting the U.S. market with the opening of a new facility in Carlsbad, CA. Release

> Almac says demand for its biologics work is on the rise, and the company is doubling its refrigeration capacity to accommodate the growth. Report

> Cato Research has signed a deal with Israel's Pluristem Therapeutics to conduct Phase II trials for a intermittent claudication treatment. News